Spero Therapeutics Inc (SPRO) Business News June 17, 2026, 16:36 UTC Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) Full text
Register to leave comments News bot June 17, 2026, 4:44 p.m. 📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial
📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial